US 7,321,030 B2 | ||
Tumor-specific promotor and use thereof | ||
Katsuyuki Hamada, Matsuyama (Japan) | ||
Assigned to The New Industry Research Organization, Hyogo (Japan) | ||
Appl. No. 10/489,258 PCT Filed Jan. 30, 2002, PCT No. PCT/JP02/00724 § 371(c)(1), (2), (4) Date Oct. 04, 2004, PCT Pub. No. WO03/025190, PCT Pub. Date Mar. 27, 2003. |
||
Claims priority of application No. 2001-279088 (JP), filed on Sep. 14, 2001. | ||
Prior Publication US 2005/0031591 A1, Feb. 10, 2005 | ||
Int. Cl. C07H 21/04 (2006.01); C12N 15/36 (2006.01) |
U.S. Cl. 536—24.1 [435/320.1; 435/325] | 3 Claims |
1. An isolated or synthesized polynucleotide sequence consisting of nucleotides 1126-2941 or 2501-2941 of SEQ ID NO: 1. |